z-logo
Premium
Study on a 65‐mer peptide mimetic enzyme with GPx and SOD dual function
Author(s) -
Yin Juxin,
Zhuang Jianjian,
Lv Shaowu,
Mu Ying
Publication year - 2018
Publication title -
journal of molecular recognition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.401
H-Index - 79
eISSN - 1099-1352
pISSN - 0952-3499
DOI - 10.1002/jmr.2714
Subject(s) - glutathione peroxidase , superoxide dismutase , antioxidant , biochemistry , reactive oxygen species , chemistry , peroxidase , peptide , glutathione , enzyme , hydrogen peroxide , microbiology and biotechnology , biology
Excessive reactive oxygen species (ROS) levels are harmful to the body. The peroxidase, GPx, and the superoxide dismutase, SOD, are important antioxidant enzymes for preventing ROS‐induced damage. Se‐CuZn‐65P is an enzyme mimetic with dual GPx and SOD antioxidant function. However, currently, its production is mainly based on the cysteine auxotrophic expression technique, which is inefficient, expensive, and time consuming. In this study, we combined protein engineering and the chemical mutation method to synthesize Se‐CuZn‐65P. The DNA sequence encoding the 65 amino acid peptide with the desired sequence transformations to incorporate the SOD and the GPx catalytic sites was cloned and expressed in a soluble protein expression vector. The protein yield increased up to 152 mg/L, which is 10 times higher than in previous studies. The SOD and GPx activity of Se‐CuZn‐65P was high (1181 U/mg and 753 U/μmol, respectively). The binding constant of glutathione was 5.6 × 10 4  L·mol −1 , which shows that Se‐CuZn‐65P efficiently catalyzed hydrogen peroxide reduction by glutathione. Mitochondrial damage experiments confirmed the double protective role of the Se‐CuZn‐65P peptide and demonstrated functional synergy between the SOD and the GPx domains, which indicates its potential to be used in the treatment of ROS‐related diseases. Our research may give a new thought to increase the yield of mimic.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here